Press release
Knowbella Tech and doDOC™ Partner to Integrate doDOC™ Content Management System Platform into Knowbella Platform™.
Knowbella Tech's Helix token
Cincinnati, OH and Boston, MA – June 26, 2018 - Knowbella Tech LLC, a scientific collaboration platform company, and doDOC, a document creation and management tool company, have partnered. Knowbella Platform™ will freely provide its scientific users with the doDOC scientific manuscript development tool.
According to Mark Pohlkamp, CEO of Knowbella Tech, “The Knowbella Tech scientific collaboration platform is being designed to provide researchers an end-to-end scientific ecosystem experience. After providing scientists with free non-therapeutic intellectual properties to collaborate around, it is important to enable those researchers to develop manuscripts they can submit to our preprint server so open access journals can review them for publication”.
According to Federico Cismondi, CEO of doDOC, “doDOC is helping researchers collaborate with scientific manuscripts in a way they have never experienced before. doDOC enable teams to work together on the same documents at the same time, drastically accelerating the authoring and review processes. With doDOC, scientists can write documents with the highest complexity of contents, seamlessly using citations from several popular repositories like Mendeley, PubMed, Scopus and EndNote. Our partnership with Knowbella Tech is aligned with our vision to define the next generation of scientific collaboration platforms, with complete focus on science development, high-quality content and value.”
The Knowbella Platform™ alpha version is scheduled for release within sixty days. More information will be provided at that time.
About Knowbella Tech LLC
Its mission is crowdsourcing the global scientific community around orphan and dormant intellectual properties to advance science and generate a public good. The freely available Knowbella Platform that will result from a successful SEC-compliant Securities Token Offering (STO) will enable scientists to collaborate around advancing technologies. Scientists will be rewarded for their conduct of science within the Platform with Helix™, “The Currency of Science™.”
About doDOC Corp.
doDOC’s mission is to change the way that complex documents are produced, from draft to publishing. Scientific documents are among the most complex ones due to their contents and strict layout design. With doDOC, scientists not only save time, but they also produce higher quality of publications due to an open channel for collaboration with their colleagues, full traceability and control of their actions, and a virtually infinite library of citations and layouts following journals specifications. doDOC is a powerful and flexible cloud-based software, scaled to meet the needs of any business, from startups to global companies.
Knowbella Tech contact:
Mark Pohlkamp, CEO
+1.513.260.4400
Mark@Knowbella.Tech
https://Knowbella.Tech
Twitter: @Knowbella
Telegram: https://t.me/knowbella
doDOC Corp contact:
Federico Cismondi, CEO
+1.617.806.6635
sales@dodoc.com
https://dodoc.com/
Twitter: @doD0C
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Knowbella Tech and doDOC™ Partner to Integrate doDOC™ Content Management System Platform into Knowbella Platform™. here
News-ID: 1098857 • Views: …
More Releases from Knowbella Tech
Knowbella Tech Selected as Finalist for 2019 SXSW Pitch
Knowbella Tech to showcase the Knowbella Platform™ in the blockchain category
Cincinnati, OH — January 9th, 2019 — Knowbella Tech, an open science collaboration platform company, was selected as a finalist in the Blockchain category for the 11th annual SXSW Pitch® (formerly SXSW Accelerator).
SXSW Pitch is the marquee event of South by Southwest® (SXSW®) Conference & Festivals (March 8-17, 2019) Entrepreneurship & Startup Track, where leading startups from around…
Knowbella Files Form 1-A with the U.S. SEC to Launch Regulation A+ STO
One of the first to file a regulated Initial Coin Offering (ICO) with the U.S. Securities and Exchange Commission.
Cincinnati, Ohio – June 13, 2018 - Knowbella Helix Inc. (“Knowbella” or the “Company”), a scientific collaboration company, today announced that on June 7, 2018, it filed an Offering Statement on Form 1-A with the Securities and Exchange Commission to launch a Regulation A+ securities token offering (STO) in the United States.…
Knowbella Tech Announces Intent to Conduct First Tier 2 Regulation A+ Initial Co …
Would be one of the first to file Initial Coin Offering to the US Securities and Exchange Commission.
Cincinnati, Ohio – February 28, 2018 - Knowbella Tech LLC, a scientific collaboration company, announces it intends to file an offering statement with the United States Securities and Exchange Commission (SEC) to conduct a $50 million Regulation A+ securities offering in the United States.
“Until now no initial coin offering, or ICO, has raised…
More Releases for Helix
Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop …
Myc Proto Oncogene Protein
Overview
Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) - Myc (c-Myc) protein encoded by Myc gene, a regulator gene that code for a transcription factor. The protein plays a role in cell cycle progression, apoptosis and cellular transformation. Myc protein is a transcription factor that activates expression of many genes through binding enhancer box sequences and recruiting…
Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop …
"The Report Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) pipeline Target constitutes close to 14 molecules. Out of which approximately 10…
The Helix by Inkcups Offers New Features for Enhanced Printing Techniques
Inkcups’ new rotary inkjet printer, The Helix, has made an immense impact in the industrial printing market since its release. This new and improved printer allows the user to print a clear, accurate, and contoured (if applicable) image in any direction and on any straight-walled or tapered cylinder. The Helix rotary inkjet printer achieves a superior balance between speed and image quality due to its patented Helix software which places…
Maxtena Launches New GPS Helix Antenna Tuning Kit
U.S. based Maxtena, a top developer and producer for innovative wireless solutions, have created the first GPS helix antenna tuning kit aimed at simplifying embedded antenna integrations.
Maxtena designed the tuning kit to empower hardware developers working on devices requiring an embedded antenna configuration. The tuning kit allows for both quick and easy antenna selection and removes the need for a lengthy and costly custom antenna integration process. The use of…
Helix Launches New Responsive Website
WEST MALLING, KENT, England, 22 August 2013
The range of web solutions offered by Helix Websites has expanded considerably in the last couple of years and their advanced new website provides a platform to showcase all the products and features they are able to offer including responsive design functionality. Their new mobile-ready site uses latest technologies, search engine optimization techniques, and design elements that Helix customers can expect in their…
Harmonised GCP Training Courses Launched by Helix Research Center
Inspired by the initiative of Sponsors of ICH ( International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals of Human Use) Viz,European Agency for the Evaluation of Medicinal Products ( EMEA),Japanese Ministry of Health,Labour and Welfare (JMHLW) and the US Food and Drug Administration (USFDA) , the Co Sponsors;Viz ,the European Federation of Pharmaceutical Industries' Associations (EFPIA),the Japanese Pharmaceutical Manufacturers Association (JPMA),the Pharmaceutical Research and Manufacturers of…
